P

Paras Healthcare Ltd.

NSE & BSE
Upcoming IPOOpens on 21 Oct 2026

₹660–693

₹ 1,522 Cr

21 Shares

₹ 13,860

₹1

Financial Summary

Consolidated(in ₹ million)
ParticularsFY 2025-26FY 2024-25
16,059.5212,940.63
228.32201.44
16,287.8413,142.07
12,899.7111,547.84
760.33-500.36
438.34-579.83

Subscription Details

Subscription data not yet available

IPO Timeline

IPO Offer Start

21 Oct 2026

IPO Offer Ends

23 Oct 2026

TBA

Use of Proceeds

#PurposeAmount (₹ Million)
1Prepayment or scheduled re-payment of a portion of certain outstanding borrowings availed by our Com3,209
2Investment in our wholly owned Subsidiary, PMHPL (which also operates our hospital in Srinagar)541

Promoters

Dharminder Kumar Nagar

Book Running Lead Managers

JM Financial Ltd.BofA Securities India Ltd.Nuvama Wealth Management Ltd.

Promoter Shareholding

Pre-IPO

75.32%

Promoter stake

Offered to Public

2,09,23,520

shares

IPO Registrar

MUFG Intime India Pvt Ltd.

About the Company

We are the fifth largest healthcare provider in terms of bed capacity in North India, Bihar and Jharkhand among our Peers, with an aggregate of 2,135 beds, as of March 31, 2024. (Source: CRISIL Report) We have eight hospitals that we operate under the “Paras Health” brand, which are spread across five states and one union territory in North India – Gurugram and Panchkula in Haryana; Patna and Darbhanga in Bihar; Kanpur, Uttar Pradesh; Udaipur, Rajasthan; Ranchi, Jharkhand; and Srinagar in the union territory of Jammu and Kashmir. Our core focus is on providing specialized tertiary medical care in Tier 2 and 3 cities, while seeking to strike a balance between providing quality healthcare services and affordability. We offer several clinical specialties across our hospitals including cardiac sciences, oncology, neuro sciences, gastro sciences and orthopedics and joint replacement. We have established centres of excellence across our hospitals, where we provide clinical specialties and these centres have been instrumental in launching new programs including organ transplant programs. Our extensive 18 years of experience in the healthcare industry in North India has helped us develop a strong understanding of the region’s market dynamics. This, along with our flexible operating model have enabled us to build an asset light business with strong unit economics.

Use of Proceeds

1. Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by our Company2. Investment in our wholly owned Subsidiary, PMHPL (which also operates our hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL3. General corporate purposes

IPO FAQs

The Paras Healthcare Ltd. IPO has a total of ₹1,522 crore, calculated at the upper end of the .

The Paras Healthcare Ltd. IPO is priced at ₹660–693 per share. bids must fall within this , against a of ₹1 per share.

The for the Paras Healthcare Ltd. IPO is 21 shares, which is also the minimum order quantity — you have to apply for at least 21 shares, and in multiples of 21 beyond that.

The minimum investment in the Paras Healthcare Ltd. IPO is about ₹13,860 — one lot of 21 shares, calculated at the lower end of the .

Bidding at the cut-off or upper price raises the amount blocked in your account.

The Paras Healthcare Ltd. opens on 21 Oct 2026 and closes on 23 Oct 2026.

Applications have to be in before 5:00 PM IST on the closing day, and your UPI mandate needs to be approved by then as well.

MUFG Intime India Pvt Ltd. is the for the Paras Healthcare Ltd. IPO.

The registrar processes the , refunds and the credit of shares to your demat account, so allotment-status queries go to them — email rnt.helpdesk@in.mpms.mufg.com.

Paras Healthcare Ltd. IPO shares are proposed to be listed on BSE and NSE.

Each Paras Healthcare Ltd. share has a of ₹1.

Face value is the nominal value recorded in the company's books and is separate from the issue price you pay.

held 75.32% of Paras Healthcare Ltd. before the IPO.

2,09,23,520 shares of Paras Healthcare Ltd. are being offered to the public in this issue.

  1. 1.Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by our Company
  2. 2.Investment in our wholly owned Subsidiary, PMHPL (which also operates our hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL
  3. 3.General corporate purposes

JM Financial Ltd., BofA Securities India Ltd. and Nuvama Wealth Management Ltd. are the for the Paras Healthcare Ltd. IPO.

Pre-apply means placing your Paras Healthcare Ltd. application before the subscription window actually opens. The bid is held and forwarded to the exchange on the opening day, so you don't have to submit it in the rush of the first morning.

Applying early doesn't improve your chances — when an issue is oversubscribed, the for investors is decided by a lottery, not by who applied first. Your money is only blocked once the application reaches the exchange.

You can apply in the Paras Healthcare Ltd. IPO online using either UPI or ASBA as the payment method. ASBA applications are made through the net banking of a bank account that supports IPO applications — the bank blocks the amount in your account instead of debiting it. UPI applications are offered by brokers that don't provide banking services: you enter your UPI ID and then approve the mandate request in your UPI app.

Either route needs a demat account. You bid for at least one lot, at a price within the or at the cut-off price, and the money stays blocked in your bank account until the is finalised.

Your broker or bank confirms the bid once it has been submitted to the exchange, usually within a few minutes during the bidding window. A UPI application only goes live after you approve the mandate request — ignore it and the bid lapses, even though it looks placed.

You can check the Paras Healthcare Ltd. bid independently on the NSE or BSE IPO bid-verification page a day after applying. An ASBA application also shows up as a blocked amount in your bank statement.